That's why RAP extended the vote for at least 2 weeks so share holders can digest the announcement. Clearly they waited until the best and final offer from Pfizer to provide an alternate solution if the NO vote gets up.
Ann: Adjournment of Scheme Meeting to a date to be determined, page-67
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #